Carlsmed (CARL) Price to Sales (2025 - 2026)

Carlsmed's (CARL) quarterly Price to Sales came in at 14.92 in Q2 2026, down 2.25% quarter-over-quarter from 15.26 in Q1 2026.

Analysis

Carlsmed (CARL) Price to Sales (2025 - 2026) Analysis & Trends

Carlsmed (CARL) has reported Price to Sales for 2 consecutive years, with 14.92 the latest figure, recorded in Q2 2026.

For the quarter ending Q2 2026, Price to Sales changed N/A year-over-year to 14.92; the trailing twelve-month figure through Jun 2026 stood at 4.46 (changed N/A YoY), and the FY2025 full-year result was 3.48, changed N/A from the prior year.
Price to Sales slipped to 14.92 in Q2 2026 per CARL's latest filing, from 15.26 in the prior quarter.
Across five years, Price to Sales topped out at 21.59 in Q3 2025 and bottomed at 11.58 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn
9	Resmed	32.94 Bn	31.47 Bn	861.22 Mn
10	Carlsmed	424.72 Mn	311.42 Mn	14.54 Mn

Historic Data

Download Data